Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01160211
Title A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

Her2-receptor positive breast cancer

Therapies

Lapatinib + Trastuzumab

Letrozole

Anastrozole

Lapatinib

Trastuzumab

Exemestane

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
Novartis Investigative Site La Jolla California 92093-0987 United States Details
Novartis Investigative Site Pleasant Hill California 94523 United States Details
Novartis Investigative Site Hollywood Florida 33021 United States Details
Novartis Investigative Site Miami Florida 33145 United States Details
Novartis Investigative Site Augusta Georgia 30912 United States Details
Novartis Investigative Site Lawrenceville Georgia 30046 United States Details
Novartis Investigative Site Chicago Illinois 60611-2906 United States Details
Novartis Investigative Site Goshen Indiana 46526 United States Details
Novartis Investigative Site Waterloo Iowa 52132 United States Details
Novartis Investigative Site Grand Rapids Michigan 49503 United States Details
Novartis Investigative Site Minneapolis Minnesota 55407-3799 United States Details
Novartis Investigative Site Billings Montana 59102 United States Details
Novartis Investigative Site Omaha Nebraska 68114 United States Details
Novartis Investigative Site Albuquerque New Mexico 87106 United States Details
Novartis Investigative Site Albuquerque New Mexico 87110 United States Details
Novartis Investigative Site Cary North Carolina 27518 United States Details
Novartis Investigative Site Dayton Ohio 45420 United States Details
Novartis Investigative Site Germantown Tennessee 38138 United States Details
Novartis Investigative Site Houston Texas 77030 United States Details
Novartis Investigative Site Tacoma Washington 98405 United States Details
Novartis Investigative Site Milwaukee Wisconsin 53226 United States Details
Novartis Investigative Site Berazategui Buenos Aires B1880BBF Argentina Details
Novartis Investigative Site Capital Federal Buenos Aires C1417DTN Argentina Details
Novartis Investigative Site Ciudad Aut6noma de Buenos Aires Buenos Aires C1050AAK Argentina Details
Novartis Investigative Site Ciudad Autonoma de Buenos Aires Buenos Aires C1125ABD Argentina Details
Novartis Investigative Site Ciudad Autonoma de Buenos Aires Buenos Aires C1280AEB Argentina Details
Novartis Investigative Site La Plata Buenos Aires B1920CMK Argentina Details
Novartis Investigative Site Viedma Río Negro R8500ACE Argentina Details
Novartis Investigative Site Rosario Santa Fe S2000KZE Argentina Details
Novartis Investigative Site Ciudad Autonoma de Buenos Aires C1025ABH Argentina Details
Novartis Investigative Site Cordoba X5004FHP Argentina Details
Novartis Investigative Site La Rioja F5300COE Argentina Details
Novartis Investigative Site Quilmes 1878 Argentina Details
Novartis Investigative Site San Miguel de Tucuman T4000IAK Argentina Details
Novartis Investigative Site Box Hill Victoria 3128 Australia Details
Novartis Investigative Site Wodonga Victoria 3690 Australia Details
Novartis Investigative Site Adelaide 5000 Australia Details
Novartis Investigative Site Douglas 4814 Australia Details
Novartis Investigative Site Ringwood East 3135 Australia Details
Novartis Investigative Site Tweed Heads 2485 Australia Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Liege 4000 Belgium Details
Novartis Investigative Site Namur 5000 Belgium Details
Novartis Investigative Site Fortaleza Ceará 60430-230 Brazil Details
Novartis Investigative Site Goiania Goiás 74605-070 Brazil Details
Novartis Investigative Site Porto Alegre Rio Grande Do Sul 90470-340 Brazil Details
Novartis Investigative Site Porto Alegre Rio Grande Do Sul 91350-200 Brazil Details
Novartis Investigative Site Barretos São Paulo 14784-400 Brazil Details
Novartis Investigative Site Sao Paulo São Paulo 01317-001 Brazil Details
Novartis Investigative Site Sao Paulo São Paulo 01323-903 Brazil Details
Novartis Investigative Site Sao Paulo São Paulo 03102-002 Brazil Details
Novartis Investigative Site Sao Paulo São Paulo 05651-901 Brazil Details
Novartis Investigative Site Rio de Janeiro 20560-120 Brazil Details
Novartis Investigative Site Plovdiv 4004 Bulgaria Details
Novartis Investigative Site Sofia 1330 Bulgaria Details
Novartis Investigative Site Sofia 1756 Bulgaria Details
Novartis Investigative Site Sofia 1784 Bulgaria Details
Novartis Investigative Site Varna 9010 Bulgaria Details
Novartis Investigative Site Calgary Alberta T2N 4N2 Canada Details
Novartis Investigative Site Fuzhou Fujian 350001 China Details
Novartis Investigative Site Guangzhou Guangdong 510060 China Details
Novartis Investigative Site Changchun Jilin 130021 China Details
Novartis Investigative Site Harbin 150081 China Details
Novartis Investigative Site Shanghai 200032 China Details
Novartis Investigative Site Monteria Colombia Details
Novartis Investigative Site Osijek 31000 Croatia Details
Novartis Investigative Site Pula 52100 Croatia Details
Novartis Investigative Site Zagreb 10000 Croatia Details
Novartis Investigative Site Besancon 25030 France Details
Novartis Investigative Site Le Mans 72000 France Details
Novartis Investigative Site Lille 59000 France Details
Novartis Investigative Site Montpellier Cedex 5 34298 France Details
Novartis Investigative Site Nancy 54100 France Details
Novartis Investigative Site Paris Cedex 20 75970 France Details
Novartis Investigative Site Heidelberg Baden-Wuerttemberg 69115 Germany Details
Novartis Investigative Site Tuebingen Baden-Wuerttemberg 72076 Germany Details
Novartis Investigative Site Muenchen Bayern 80335 Germany Details
Novartis Investigative Site Muenchen Bayern 81675 Germany Details
Novartis Investigative Site Regensburg Bayern 93053 Germany Details
Novartis Investigative Site Rosenheim Bayern 83022 Germany Details
Novartis Investigative Site Fuerstenwalde Brandenburg 15517 Germany Details
Novartis Investigative Site Rostock Mecklenburg-Vorpommern 18059 Germany Details
Novartis Investigative Site Goslar Niedersachsen 38642 Germany Details
Novartis Investigative Site Hannover Niedersachsen 30559 Germany Details
Novartis Investigative Site Aachen Nordrhein-Westfalen 52066 Germany Details
Novartis Investigative Site Bottrop Nordrhein-Westfalen 46236 Germany Details
Novartis Investigative Site Troisdorf Nordrhein-Westfalen 53840 Germany Details
Novartis Investigative Site Velbert Nordrhein-Westfalen 42551 Germany Details
Novartis Investigative Site Halle Sachsen-Anhalt 06120 Germany Details
Novartis Investigative Site Kiel Schleswig-Holstein 24103 Germany Details
Novartis Investigative Site Berlin 10317 Germany Details
Novartis Investigative Site Berlin 12200 Germany Details
Novartis Investigative Site Hamburg 20246 Germany Details
Novartis Investigative Site Hamburg 22081 Germany Details
Novartis Investigative Site Hamburg 22087 Germany Details
Novartis Investigative Site Athens 115 28 Greece Details
Novartis Investigative Site Chania 73100 Greece Details
Novartis Investigative Site Heraklion 71110 Greece Details
Novartis Investigative Site Perioxi Dragana, Alexandroupolis 68100 Greece Details
Novartis Investigative Site Hong Kong Hong Kong Details
Novartis Investigative Site Kowloon Hong Kong Details
Novartis Investigative Site Pokfulam Hong Kong Details
Novartis Investigative Site Tuen Mun Hong Kong Details
Novartis Investigative Site Budapest 1032 Hungary Details
Novartis Investigative Site Budapest 1125 Hungary Details
Novartis Investigative Site Debrecen H-4032 Hungary Details
Novartis Investigative Site Gyor H-9024 Hungary Details
Novartis Investigative Site Gyula 5700 Hungary Details
Novartis Investigative Site Kaposvar 7400 Hungary Details
Novartis Investigative Site Miskolc 3526 Hungary Details
Novartis Investigative Site Nyiregyhaza 4400 Hungary Details
Novartis Investigative Site Pecs 7624 Hungary Details
Novartis Investigative Site Szeged 6720 Hungary Details
Novartis Investigative Site Szolnok 5004 Hungary Details
Novartis Investigative Site Veszprem 8200 Hungary Details
Novartis Investigative Site Zalaegerszeg H-8900 Hungary Details
Novartis Investigative Site Bangalore 560052 India Details
Novartis Investigative Site Chennai 600116 India Details
Novartis Investigative Site Delhi 110085 India Details
Novartis Investigative Site Nagpur 440010 India Details
Novartis Investigative Site New Delhi 110 092 India Details
Novartis Investigative Site Pune 411001 India Details
Novartis Investigative Site Surat Saroli - 394601Dist - Surat India Details
Novartis Investigative Site Dublin 7 Ireland Details
Novartis Investigative Site Dublin 4 Ireland Details
Novartis Investigative Site Dublin 7 Ireland Details
Novartis Investigative Site Dublin 8 Ireland Details
Novartis Investigative Site Galway Ireland Details
Novartis Investigative Site Haifa 31096 Israel Details
Novartis Investigative Site Jerusalem 91120 Israel Details
Novartis Investigative Site Petah-Tikva 49100 Israel Details
Novartis Investigative Site Ramat Gan 52621 Israel Details
Novartis Investigative Site Rehovot 76100 Israel Details
Novartis Investigative Site Tel Aviv 69710 Israel Details
Novartis Investigative Site Parma Emilia-Romagna 43100 Italy Details
Novartis Investigative Site Piacenza Emilia-Romagna 29100 Italy Details
Novartis Investigative Site Monza Lombardia 20052 Italy Details
Novartis Investigative Site Pavia Lombardia 27100 Italy Details
Novartis Investigative Site Rozzano (MI) Lombardia 20089 Italy Details
Novartis Investigative Site San Giovanni Rotondo 71013 Italy Details
Novartis Investigative Site Aichi 464-8681 Japan Details
Novartis Investigative Site Chiba 277-8577 Japan Details
Novartis Investigative Site Ehime 791-0280 Japan Details
Novartis Investigative Site Kagoshima 892-0833 Japan Details
Novartis Investigative Site Osaka 540-0006 Japan Details
Novartis Investigative Site Osaka 565-0871 Japan Details
Novartis Investigative Site Saitama 350-1298 Japan Details
Novartis Investigative Site Saitama 362-0806 Japan Details
Novartis Investigative Site Shizuoka 411-8777 Japan Details
Novartis Investigative Site Tokyo 104-8560 Japan Details
Novartis Investigative Site Tokyo 113-8677 Japan Details
Novartis Investigative Site Tokyo 142-8666 Japan Details
Novartis Investigative Site Gyeonggi-do 10408 Korea, Republic of Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Seoul 06351 Korea, Republic of Details
Novartis Investigative Site Seoul 138-736 Korea, Republic of Details
Novartis Investigative Site Vilnius LT-08660 Lithuania Details
Novartis Investigative Site Lorenskog Norway Details
Novartis Investigative Site Miraflores Lima Lima 18 Peru Details
Novartis Investigative Site San Borja Lima Lima 41 Peru Details
Novartis Investigative Site San Isidro Lima Lima 27 Peru Details
Novartis Investigative Site Arequipa Peru Details
Novartis Investigative Site Lima Lima 18 Peru Details
Novartis Investigative Site Trujillo 44 Peru Details
Novartis Investigative Site Makati City 1218 Philippines Details
Novartis Investigative Site Quezon City 1102 Philippines Details
Novartis Investigative Site Konin 62-500 Poland Details
Novartis Investigative Site Lubin 59-301 Poland Details
Novartis Investigative Site Otwock 05-400 Poland Details
Novartis Investigative Site Warszawa 02-776 Poland Details
Novartis Investigative Site Warszawa 04-125 Poland Details
Novartis Investigative Site Wieliszew 05-135 Poland Details
Novartis Investigative Site Wroclaw 53-413 Poland Details
Novartis Investigative Site Coimbra 3000-075 Portugal Details
Novartis Investigative Site Evora 7000-811 Portugal Details
Novartis Investigative Site Lisboa 1649-035 Portugal Details
Novartis Investigative Site Lisbon 1400-038 Portugal Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site San Juan 00910 Puerto Rico Details
Novartis Investigative Site San Juan 00935 Puerto Rico Details
Novartis Investigative Site Bucharest 050098 Romania Details
Novartis Investigative Site Bucuresti 022328 Romania Details
Novartis Investigative Site Timisoara 300239 Romania Details
Novartis Investigative Site Arkhangelsk 163045 Russian Federation Details
Novartis Investigative Site Kazan 420029 Russian Federation Details
Novartis Investigative Site Moscow 115478 Russian Federation Details
Novartis Investigative Site Moscow 117997 Russian Federation Details
Novartis Investigative Site Ryazan 390011 Russian Federation Details
Novartis Investigative Site St. Petersburg 197022 Russian Federation Details
Novartis Investigative Site St. Petersburg 197758 Russian Federation Details
Novartis Investigative Site Tver 170008 Russian Federation Details
Novartis Investigative Site Belgrade 11000 Serbia Details
Novartis Investigative Site Kragujevac 34000 Serbia Details
Novartis Investigative Site Sremska Kamenica 21204 Serbia Details
Novartis Investigative Site Singapore 308433 Singapore Details
Novartis Investigative Site Cape Town 7700 South Africa Details
Novartis Investigative Site Durban 4091 South Africa Details
Novartis Investigative Site Port Elizabeth 6045 South Africa Details
Novartis Investigative Site Pretoria 0081 South Africa Details
Novartis Investigative Site Saxonwold, Johannesburg 2196 South Africa Details
Novartis Investigative Site Barcelona 08025 Spain Details
Novartis Investigative Site Barcelona 08036 Spain Details
Novartis Investigative Site Castellon 12002 Spain Details
Novartis Investigative Site Cordoba 14004 Spain Details
Novartis Investigative Site La Coruna 15009 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Santa Cruz de Tenerife 38320 Spain Details
Novartis Investigative Site Changhua 500 Taiwan Details
Novartis Investigative Site Kaohsiung Hsien 833 Taiwan Details
Novartis Investigative Site Taipei City 11217 Taiwan Details
Novartis Investigative Site Ankara Turkey Details
Novartis Investigative Site Izmir 35100 Turkey Details
Novartis Investigative Site Chernivtsi 58013 Ukraine Details
Novartis Investigative Site Dnipropetrovsk 49102 Ukraine Details
Novartis Investigative Site Kharkiv 61070 Ukraine Details
Novartis Investigative Site Khmelnytskyi 29000 Ukraine Details
Novartis Investigative Site Lyutizh 07352 Ukraine Details
Novartis Investigative Site Sumy 40005 Ukraine Details
Novartis Investigative Site Uzhgorod 88000 Ukraine Details
Novartis Investigative Site Vinnitsia 21029 Ukraine Details
Novartis Investigative Site Chelmsford Essex CM1 7ET United Kingdom Details
Novartis Investigative Site Birmingham West Midlands B18 7QH United Kingdom Details
Novartis Investigative Site Huddersfield HD3 3EA United Kingdom Details
Novartis Investigative Site London NW3 2QG United Kingdom Details
Novartis Investigative Site London SW3 6JJ United Kingdom Details
Novartis Investigative Site Maidstone ME16 9QQ United Kingdom Details
Novartis Investigative Site Manchester M20 4BX United Kingdom Details
Novartis Investigative Site Nottingham NG5 1PB United Kingdom Details
Novartis Investigative Site Peterborough PE3 9GZ United Kingdom Details
Novartis Investigative Site Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field